A novel designed drug delivery system to lure and kill cancer cells. This project is just an idea of a system, and has not been physically created nor tested.
2. Current treatment for Cancer
1. Chemotherapy
2. Surgery
3. Radiation Therapy
4. Immunotherapy
5. Targeted Therapy
6. Hormone Therapy
7. Stem Cell Transplant
Disadvantages
Cancer cells and healthy cells
affected
Cancer does not always go
away
Severely impacted daily
activities of patients
Patient still has bad quality of
life and dies from cancer/
treatment
3. Design Concept and Hypothesis
Design a biodegradable device for controlled drug
release that targets and lures cancer cells
BioSilicon Polymer
Anti-folate drugs
Biguanide (Type II Diabetic Drugs)
Cytokines Cancer Bait
4. Case Study Flowchart
34 year old male
Mandibular cancer
Efficient vasculature in the
head and neck
Easy metastasis
Problems – Primary tumor and
Metastasis
Solution– 1 Solution to 2
issues.
5. BioSilicon
Porous Form of
Silicon
Degrades into Silicic
Acid
Semiconductor
Photoetching
Rezos, Gavin. "Nanostructured Silicon - Appilcations in Drug Delivery." Drug
Delivery & Formulations. PSivida. 64-67. Print.
6. Drug Delivery Applications
Drug loading up to 95%
Controlled Time Release (hours, weeks, months)
Conduction Charges
Structural protection
Biocompatible and Biodegradable
Many medical applications and delivery formulations
7. Anti-folate Drug Class
Inhibit cancer cells synthesis of folic
acid
Folic acid is found in cancer cells and
is their nutrient source to make
protein for further proliferation
Common examples: aminopterin, and
methoxtrexate
Mechanism
1. Inhibit dihydrofolate reductase-
prevents reduction of folic acid and
dihydrofolic acid to THF
2. Inhibit thymidylate synthase
"Folic Acid Metabolism: A Role in Cancer's Cause and Cure |
BioFiles Volume 5 Number 6 - Cancer." Sigma-Aldrich. N.p., n.d.
Web. 18 Oct. 2015. <http://www.sigmaaldrich.com/life-
science/learning-center/biofiles/biofiles-5-6/folic-acid-
metabolism.html>.
8. Biguanides Type II Diabetes Drugs
Common Examples: Metformin, Phenformin
Mechanism of action
1. Leads to increase in AMP
2. Blocks enzyme adenylate cyclase
3. Reduces levels of cyclic AMP and protein kinase
activity
4. Blocks glucose-dependent glucose output from
liver cells
9. Published OnlineFirst March 31, 2012, doi: 10.1158/1078-0432.CCR-12-0694Clin Cancer Res May 15, 2012 vol.
18 no. 10 2723-2725
10. How It Works
Birnbaum, Morris J. "Penn Team Finds That Most-Used Diabetes Drug Works in Different Way than Previously
Thought." Penn Team Finds That Most-Used Diabetes Drug Works in Different Way than Previously Thought. The
Trustees of the University of Pennsylvania, 07 Jan. 2013. Web. 12 Oct. 2015.
11. Drug Combination Therapy
Anti-folate drugs in excess is associated with DNA
damage and altered DNA methylation
Cases have been seen that excess of biguanides in
non-diabatic patients cause severe lactic acidosis
No known drug interactions between the two.
12. Cytokines as Cancer Lure
Cytokines are signaling proteins that are produced by white
blood cells.
Mediate and regulate immune responses, inflammation, and
hematopoiesis.
Three types of cytokines
Interferons (INFs)
Interleukins (ILs)
Hematopoietic Growth Factors
16. In Vivo Study
Inject cancer cells into
breast tissue of female
mice
Biosilicon device
implant near the site
of tumor
Inflammation and
Cytokines Lure Cancer
Cells
Surface Degradation
induces drug release
17. Take Home Message
1) Coat the implant with cytokines, that draws out as many malignant cells
as possible.
2) Have a multitude of drugs embedded into the implant that are released
as the scaffold resorbs.
3) Make sure the drugs have different mechanisms of action and no
interactions with each other.
4) Surgical implantation as close as possible to the primary tumor.
5) Inflammation lures cancer cells into region
18. Possible Alterations
1
• Change concentration of the drugs used
2
• Change the degradation rate of the BioSilicon polymer
3
• Use different combinations of drugs
19. Limitations
Dependent on the inflammatory response of individual
patients
Biguanides have not been established as anti-neoplastic drug
Limited to early stages of cancer prognosis
20. References
(Slide 2) "Types of Treatment." National Cancer Institute. National Cancer Institute, n.d. Web. 18 Oct. 2015. <http://www.cancer.gov/about-
cancer/treatment/types>.
(Slide 8) Rezos, Gavin. "Nanostructured Silicon - Appilcations in Drug Delivery." Drug Delivery & Formulations. PSivida. 64-67. Print.
(Slide 10) "Folic Acid Metabolism: A Role in Cancer's Cause and Cure | BioFiles Volume 5 Number 6 - Cancer." Sigma-Aldrich. N.p., n.d. Web. 18 Oct.
2015. <http://www.sigmaaldrich.com/life-science/learning-center/biofiles/biofiles-5-6/folic-acid-metabolism.html>.
(Slide 12) Pollak, Michael. "Metformin and Pancreatic Cancer: A Clue Requiring Investigation." Clinical Cancer Research. American Association for
Cancer Research, 31 Mar. 2012. Web. 18 Oct. 2015. <http://clincancerres.aacrjournals.org/citmgr?gca=clincanres%3B18%2F10%2F2723>.(Slide 11-13)
Birnbaum, Morris J. "Penn Team Finds That Most-Used Diabetes Drug Works in Different Way than Previously Thought." Penn Team Finds That Most-
Used Diabetes Drug Works in Different Way than Previously Thought. The Trustees of the University of Pennsylvania, 07 Jan. 2013. Web. 12 Oct. 2015.
(Slide 11-13) Kıvanç Birsoy, Richard Possemato , Franziska K. Lorbeer, Erol C. Bayraktar, Prathapan Thiru, Burcu Yucel, Tim Wang, Walter W. Chen, Clary
B. Clish, and David M. Sabatini.“Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides”Nature, March 16, 2014.
(Slide 14) Suchard, Jeffrey R., and Thomas A. Grotsky. “Fatal Metformin Overdose Presenting with Progressive Hyperglycemia.” Western Journal of
Emergency Medicine 9.3 (2008): 160–164. Print.
(Slide 14) Drugs.com [Internet]. Metformin Information from Drugs.com; c2000-15 [updated: 2015 October 11; Cited 2015 October 18]. Available from:
http://www.drugs.com/drug-interactions/metformin.html
"Tiny 'Cancer Trap' Could Stop Cancer Spread." NHS Choices. Bazian, 9 Sept. 2015. Web. 9 Oct. 2015.
Editor's Notes
Avoid toxicity effect in the body
Published OnlineFirst March 31, 2012, doi: 10.1158/1078-0432.CCR-12-0694Clin Cancer Res May 15, 2012 vol. 18 no. 10 2723-2725